Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TRIB
TRIB logo

TRIB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Trinity Biotech PLC (TRIB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.700
1 Day change
3.53%
52 Week Range
3.440
Analysis Updated At
2026/05/22
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

TRIB is not a good buy right now for a beginner long-term investor with $50,000-$100,000. The stock is trading near a pivot level with mixed short-term momentum, but the broader moving average structure is still bearish and there is no strong proprietary buy signal. With no recent news catalysts, no positive analyst upgrade trend, and no financial snapshot available to support a long-term thesis, the setup does not justify an immediate purchase.

Technical Analysis

Current price is 0.6003, essentially flat on the day, with pre-market showing -2.02%, which suggests some early weakness. MACD histogram is positive and expanding, so near-term momentum has improved slightly. However, the moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, which is a weak long-term trend structure. RSI_6 at 69.557 is elevated but still not a clear overbought breakout signal. Price is sitting near the pivot at 0.599, with resistance at 0.632 and 0.652 and support at 0.566 and 0.546. Overall, the chart is short-term neutral to slightly positive, but long-term trend quality remains poor.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is extremely bullish by positioning, with open interest put-call ratio at 0.02 and volume put-call ratio at 0.0. Call open interest (744) far exceeds put open interest (15), and today’s options volume was entirely call-driven. Implied volatility is extremely high at 890.69, with IV percentile 99.21 and IV rank 98.21, indicating very expensive options and elevated speculation rather than stable long-term conviction.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
7

Positive Catalysts

  • No news in the recent week limits event-driven upside. Technical momentum via the positive MACD histogram is a minor constructive factor, and the similar-pattern stock trend estimate suggests modest upside over the next week and month.

Neutral/Negative Catalysts

  • No recent news catalysts, no significant hedge fund activity, no insider buying trends, no recent congressional trading, and no meaningful AI Stock Picker or SwingMax signal. The bearish moving average alignment remains the main technical weakness. The lack of financial snapshot data also makes it hard to support a long-term buy case.

Financial Performance

Latest quarter financials could not be assessed because the financial snapshot returned an error and no quarter season was available. That means there is no usable recent revenue, earnings, or growth data to support a long-term investment decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no evidence of a recent bullish upgrade cycle or rising target trend. From a Wall Street pros-and-cons perspective, the main pro is speculative options interest, while the cons are the weak long-term trend, lack of news catalysts, and absence of confirmed fundamental support.

Wall Street analysts forecast TRIB stock price to rise
Analyst Rating
0
Wall Street analysts forecast TRIB stock price to rise
Buy
Hold
Sell
0
Current: 0.704
sliders
Low
0
Averages
0
High
0
0
Current: 0.704
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch